Incidental findings on a Tc99m-SESTAMIBI parathyroid scan post COVID-19 vaccination

Mitchel A Muhleman; Jorge D Oldan; Amir H Khandani

Incidental findings on a Tc99m-SESTAMIBI parathyroid scan post COVID-19 vaccination

Am J Nucl Med Mol Imaging. 2022 Apr 15;12(2):71-73. eCollection 2022.

Authors

Mitchel A Muhleman¹, Jorge D Oldan¹, Amir H Khandani¹

Affiliation

¹ Division of Molecular Imaging and Therapeutics, Department of Radiology, University of North Carolina School of Medicine Chapel Hill, NC, USA.

PMID: 35535123
PMCID: PMC9077171

Abstract

We present a case of abnormal findings on a Tc99m-Sestamibi parathyroid scan, post COVID-19 vaccination. The patient is a 48-year-old female presenting for evaluation of hyperparathyroidism who received the mRNA-1273 Moderna (ModernaTX, Inc.) vaccine seven days prior to the scan. The patient is right hand dominant and reported no traumatic events, inflammation, infection, or extraneous use of the left arm. The patient did report "soreness" of the extremity starting approximately 24 hours post injection which continued to the time of the study.

Keywords: COVID-19 vaccination; Tc99m-Sestamibi increased uptake.